Home › Calculator › NMRA Dividend Calculator 2026
NMRA Dividend Calculator 2026
No dividendHealthcareNeumora Therapeutics, Inc. Common Stock · NASDAQ
Price: $0.38 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
NMRA is not a dividend-focused stock
NMRA pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
NMRA Dividend Yield
Neumora Therapeutics, Inc. Common Stock (NMRA) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NMRA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Neumora Therapeutics, Inc. Common Stock (NMRA) — Dividend Analysis 2026
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
NMRA Dividend & DRIP — Frequently Asked Questions
Does NMRA pay a dividend?
No. Neumora Therapeutics, Inc. Common Stock (NMRA) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of NMRA?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does NMRA have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. NMRA has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to NMRA
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NMRA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NMRA position with:
🌍 NMRA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NMRA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NMRA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NMRA Dividend Payment Schedule
NMRA pays quarterly — 4 times per year. Ex-div: —.
📊 NMRA vs Healthcare Benchmarks
How NMRA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NMRA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NMRA Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-08-20 | 200,000 | $1.52 | $304.0K | ||
| M-Exempt | 2026-08-20 | 67,741 | $0.72 | $48.8K | ||
| M-Exempt | 2026-08-20 | 21,685 | $0.72 | $15.6K | ||
| M-Exempt | 2026-08-20 | 67,741 | $0.72 | $48.8K | ||
| M-Exempt | 2026-08-21 | 21,055 | $0.72 | $15.2K | ||
| M-Exempt | 2026-08-21 | 20,553 | $0.72 | $14.8K | ||
| M-Exempt | 2026-08-21 | 20,553 | $0.72 | $14.8K | ||
| M-Exempt | 2026-08-20 | 45,026 | $0.72 | $32.4K | ||
| Sale | 2026-08-20 | 67,741 | $1.51 | $102.6K | ||
| Sale | 2026-08-21 | 20,553 | $1.59 | $32.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare NMRA with peers: NMRA vs ADCT · NMRA vs ALMS · NMRA vs AUTL
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NMRA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Neumora Therapeutics, Inc. Common Stock (NMRA) is currently trading at $0.38, 90% below its 52-week high. It does not currently pay a regular dividend.
Does NMRA Pay a Dividend? Neumora Therapeutics, Inc. Common Stock Dividend Status
Neumora Therapeutics, Inc. Common Stock (NMRA) is a healthcare stock trading at $0.38. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest NMRA News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your NMRA DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.